Učitavanje...

Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism

A hepatic comorbidity of metabolic syndrome, known as nonalcoholic fatty liver disease (NAFLD), is increasing in prevalence in conjunction with the pandemics of obesity and diabetes. The spectrum of NAFLD ranges from simple hepatic fat accumulation to a more severe disease termed nonalcoholic steato...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Mol Gastroenterol Hepatol
Glavni autori: McCommis, Kyle S., Finck, Brian N.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6352854/
https://ncbi.nlm.nih.gov/pubmed/30686780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcmgh.2018.09.017
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!